Clinically proven semaglutide therapy — the world's most prescribed GLP-1 weight loss injection — administered under expert medical supervision for safe, significant results.
Ozempic (semaglutide) is a once-weekly injectable GLP-1 (glucagon-like peptide-1) receptor agonist developed by Novo Nordisk. Originally approved for Type 2 diabetes, its remarkable weight loss efficacy — demonstrated in the landmark STEP clinical trials — has established it as one of the most prescribed medications for medical weight management globally.
Semaglutide works by mimicking the action of the body's natural GLP-1 hormone: suppressing appetite, slowing gastric emptying, and regulating blood sugar. At DermaTales, all Ozempic programmes are fully physician-supervised, with regular monitoring, dose optimisation, and integrated nutrition support for the safest and most effective outcomes.
Semaglutide's multi-pathway action addresses several of the biological drivers of obesity and overeating:
Acts on appetite centres in the brain (hypothalamus) to significantly reduce hunger signals and food cravings throughout the day.
Delays how quickly food leaves the stomach, promoting prolonged satiety after smaller meals and reducing overall caloric intake naturally.
Stimulates glucose-dependent insulin secretion and suppresses glucagon, keeping blood sugar stable and reducing insulin resistance.
The LEADER trial demonstrated a 26% reduction in major cardiovascular events in high-risk patients on semaglutide — a unique benefit beyond weight loss.
Clinical data confirms significant reduction in liver fat content, making Ozempic particularly effective for patients with non-alcoholic fatty liver disease (NAFLD).
Marked improvements in LDL cholesterol, triglycerides, and blood pressure observed in clinical trials alongside weight loss outcomes.
Thorough medical history review, physical examination, and blood tests (HbA1c, thyroid, lipids, kidneys, liver enzymes) to confirm eligibility and establish baseline values.
Ozempic is always started at the lowest dose (0.25 mg SC weekly) for 4 weeks to allow gastrointestinal adaptation and minimise side effects.
The dose is increased every 4 weeks (0.25 → 0.5 → 1 → 2 mg) based on your tolerance and clinical response, targeting the most effective therapeutic dose.
Regular check-ins to measure weight loss progress, body composition, blood markers, and medication tolerability — with dietary and lifestyle adjustments at every visit.
Once target weight is achieved, a structured maintenance protocol — including gradual dose reduction and lifestyle reinforcement — is designed to sustain your results long-term.
Ozempic is a controlled prescription medication. We conduct a full clinical evaluation before prescribing — ensuring it is right for you and safe given your health status.
We source only authentic Ozempic from licensed distributors, with proper cold-chain management to guarantee medication efficacy and safety.
Medication is integrated with clinical nutrition planning, metabolic monitoring, and lifestyle coaching — creating a holistic programme that maximises and sustains your weight loss.
Our proactive titration protocol and dedicated medical team ensure that gastrointestinal side effects are minimised and addressed promptly throughout your treatment.